Scientists think they've discovered why the AstraZeneca COVID-19 vaccine can cause rare blood clots
Scientists in the U.K. believe they have discovered the reason why some people experienced the very rare side-effect of blood clots after receiving the AstraZeneca COVID-19 vaccine.
The findings, published in the journal Science Advances on Wednesday, reveal that a protein found in blood is drawn to a component of the vaccine, which triggers a reaction from the body’s immune system that can result in clots.
The AstraZeneca vaccine, like other viral vector vaccines, uses a safe virus as a “host” to deliver genetic information about the COVID-19 spike protein to the vaccine recipient's cells so that they can build an immune response and create antibodies.
The AstraZeneca COVID-19 vaccine uses a cold virus from a chimpanzee, also known as a chimpanzee adenovirus, as the delivery system. This is because it cannot make humans sick – and, because they have not been exposed to it before, they will not have antibodies against it.
Viral vector vaccines modify the delivery virus so that it cannot spread, they simply delivers the instructions for the body’s cells.
By analyzing the chimpanzee adenovirus used by AstraZeneca with cryo-electron microscopy, which allows for molecular-level details to be seen, researchers found that the adenovirus attracts the blood protein known as “platelet factor 4” to it.
Cryo-electron microscopy involves flash-freezing the study subject and then bombarding them with electrons to produce microscope images of individual molecules. Those are then used to reconstruct the structure of the subject in minute detail.
The cryo-electron microscopy image of the chimpanzee adenovirus, which is less than 100 nanometres across, that delivers the Oxford-AstraZeneca vaccine. (Science Advances Journal)
The cryo-electron microscopy image of the chimpanzee adenovirus which delivers the Oxford-AstraZeneca vaccine. (Science Advances Journal)
Platelet factor 4 is implicated in the origins of another clotting event called heparin-induced thrombocytopenia (HIT), which causes changes to the blood that may cause a clot to form in the blood vessels.
Researchers posit that the body begins to attack the platelets that are attached to the adenovirus, after mistaking it as part of the foreign virus. Then, when antibodies are released into the bloodstream to attack, they clump together with the platelet factor 4 and can form a dangerous blood clot known as vaccine-induced thrombotic thrombocytopenia or VITT.
Because that sequence of events in the body is so specific, it may explain why the development of blood clots after receiving the vaccine is such a rare phenomenon.
The U.K. findings echo a Canadian study conducted by researchers at McMaster University in Hamilton, Ont., and published this July in the scientific journal Nature.
In the Canadian study, researchers analyzed blood samples from five patients with VITT and compared them to blood samples of 10 patients with HIT and 10 samples from healthy individuals.
Looking at the amino acids of the interaction between the VITT antibodies and platelet factor 4 protein, researchers found eight specific amino acids on the platelet protein that were identical to the binding site of HIT, which they believe could explain the similar patterns in how the blood clots form after vaccination.
However the U.K. study was able to render the highest resolution of the adenovirus used in the AstraZeneca COVID-19 vaccine to date, allowing them to better understand its primary cell attachment proteins and its structure.
VITT has been linked to at least one death in Canada after an Ontario man received the AstraZeneca vaccine in May, and to 73 deaths out of close to 50 million doses of AstraZeneca administered in the U.K.
The Public Health Agency of Canada’s National Advisory Committee of Immunization stopped recommending AstraZeneca’s COVID-19 vaccine as a second dose option after some Canadian recipients reported blood clots in the spring of 2021.
Researchers in the U.K. hope their study findings can be used to improve future vaccines and reduce the risk of blood clots.
-----
With files from CTVNews.ca writer Brooklyn Neustaeter
COVID-19 COVERAGE
CTVNews.ca Top Stories
'Hurts like hell': What goes into the price of gas in Canada
With the price of gas rising above $2 per litre and setting new records in Canada this year, CTVNews.ca looks at what goes into the price per litre of gasoline and where the situation could go from here.

'This is an unusual situation': Feds monitoring monkeypox cases in Canada
Canada's Chief Public Health Officer Dr. Theresa Tam says the federal government is monitoring monkeypox cases and their chains of transmission after two cases were confirmed in this country.
Russia claims to have taken full control of Mariupol
Russia claimed to have captured Mariupol on Friday in what would be its biggest victory yet in its war with Ukraine, following a nearly three-month siege that reduced much of the strategic port city to a smoking ruin, with over 20,000 civilians feared dead.
'Fight for a stronger Alberta': Kenney comments for first time since announcing resignation
Premier Jason Kenney spoke publicly Friday for the first time since dropping the bombshell announcement that he plans to step down as UCP leader and premier of Alberta.
Ontario woman says daughter was discriminated against over face mask
An Ontario woman believes her daughter was discriminated against after she was allegedly kicked out of a local activity centre over her choice to wear a face mask.
WHO calls emergency meeting as monkeypox cases cross 100 in Europe
The World Health Organization was due to hold an emergency meeting on Friday to discuss the recent outbreak of monkeypox, a viral infection more common to west and central Africa, after more than 100 cases were confirmed or suspected in Europe.
NEW | Decision to ban Huawei and ZTE from 5G wasn't easy, PM Trudeau says
On the heels of news that Canada is banning Huawei Technologies and ZTE from participating in the country’s 5G wireless networks, Prime Minister Justin Trudeau said the decision wasn't easy to make. The prime minister also defended the timing of the decision, saying that while it will be years before all use of products from these Chinese companies will be outlawed, it's happening before the country is even more interconnected by the next-generation telecommunications infrastructure.
Costs reach $25.6 million for public inquiry into 2020 mass shooting in Nova Scotia
The public inquiry into Nova Scotia's mass shooting has already cost $25.6 million to investigate the April 18-19, 2020, rampage -- and there are still about five months remaining in its mandate.
Quebec City Halloween attacker found guilty of first-degree murder
A man who used a sword to kill and maim victims in Quebec City's historic district on Halloween night 2020 has been found guilty of murder.